Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1980-10-21
|
| pubmed:abstractText |
5 patients suffering from von Willebrand's syndrome were treated with DDAVP administered intravenously or intransally. The concentration of F. VIII-related activities (F. VIII:C, F. VIII R:AG, F. VIII R:WF), as well as the mobility of F. VIII R:AG in crossed immunoelectrophoresis and the alterations of bleeding time were continuously monitored. DDAVP induced both quantitative and qualitative changes of F. VIII-related properties. The bledding time was markedly reduced for some hours. The therapy was well tolerated and should be submitted to further clinical trials as a possible way to avoid the disadvantages connected with the transfusion of blood components.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0301-0147
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
204-13
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:6772527-Adolescent,
pubmed-meshheading:6772527-Arginine Vasopressin,
pubmed-meshheading:6772527-Bleeding Time,
pubmed-meshheading:6772527-Child,
pubmed-meshheading:6772527-Deamino Arginine Vasopressin,
pubmed-meshheading:6772527-Factor VIII,
pubmed-meshheading:6772527-Female,
pubmed-meshheading:6772527-Humans,
pubmed-meshheading:6772527-Immunoelectrophoresis,
pubmed-meshheading:6772527-Male,
pubmed-meshheading:6772527-Middle Aged,
pubmed-meshheading:6772527-von Willebrand Diseases
|
| pubmed:year |
1980
|
| pubmed:articleTitle |
DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
|
| pubmed:publicationType |
Journal Article
|